Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Evaluating safety and pharmacokinetics in dose escalation of WCK-771 and WCK-2349

April 14, 2016

Mul-1867 shows promising activity against multidrug-resistant Pseudomonas aeruginosa

April 14, 2016

Researchers present results from in vitro and in vivo studies of WCK-4282

April 14, 2016

Riboscience divulges respiratory syncytial virus RNA replication inhibitors

April 14, 2016

FDA grants orphan drug designation for ATI-1501

April 14, 2016

FDA grants orphan drug designation to TGV-Inhalonix's Mul-1867

April 13, 2016

Phase Ia study evaluates Ebola virus vaccination with VRC-EBOADC076-00-VP followed by MVA-EBOZ

April 13, 2016

BTA-585 enters phase IIa trial for the treatment of RSV infections

April 12, 2016

Encouraging results seen in phase II murepavadin study

April 12, 2016

Data reported from phase III study of surotomycin for CDAD

April 12, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...